In four documented kilo-scale campaigns run in stainless steel and glass-lined vessels, the coupling of (3S,4R)-4-(2-trifluoromethylphenyl)pyrrolidine-3-carboxylic acid with cycloalkylamines has shown a narrow thermal processing window. The free pyrrolidine nitrogen competes with the external amine nucleophile when the temperature exceeds 12 °C, generating 2.3–3.1% of a dimeric amide impurity that co-crystallizes with the desired dipeptidyl peptidase‑4 (DPP‑4) intermediate. Compliance with ICH M7 requires control of this impurity to ≤0.15% by HPLC (gradient 10–90% MeCN in 0.1% H₃PO₄, 1.0 mL/min). The acid is typically delivered with an enantiomeric excess of ≥99.5% determined on a Chiralpak AD‑H column (250 × 4.6 mm, 5 μm) using a hexane/ethanol/0.1% trifluoroacetic acid mobile phase (0.8 mL/min); the (3R,4S) enantiomer elutes at relative retention 1.32 and must integrate below 0.3 area%. Activation with 1.15 equivalents of 1-ethyl‑3‑(3‑dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) in the presence of 1.10 equivalents of 1‑hydroxybenzotriazole hydrate (HOBt·H₂O) and 2.5 equivalents of N‑methylmorpholine (NMM) in anhydrous tetrahydrofuran (8 volumes relative to the amine component) is carried out at a jacket set point of −2 °C. Scale‑up records from 200 L to 800 L reactors reveal that an anchor‑agitator speed below 90 rpm produces a 0.7% increase in the undesired epimer, attributed to localized overheating during EDC addition. After 16 h of gradual warming to 20 °C, the batch is quenched with 1.0 M HCl to pH 2.5, extracted with ethyl acetate, and the crude β‑alanine derivative is crystallized from ethyl acetate/n‑heptane (1:3 v/v) to reach 99.1% chemical purity. The terminal end product belongs to the gliptin class of antidiabetic agents; its crystal form is driven toward polymorph A by seeding with 0.5% w/w of micronized pure form A under controlled cooling (−0.3 °C/min).
What Regulatory Burden Accompanies a (3S,4R)-Pyrrolidine-3-carboxylic Acid Route into DPP-4 Inhibitors?
When the same carboxylic acid is incorporated into a first‑generation DPP-4 inhibitor registered under FDA NDA 021977 analogs, the entire manufacturing chain from the advanced intermediate must satisfy 21 CFR Part 211 current good manufacturing practice guidelines. The residual solvent profile of the acid batch is benchmarked against ICH Q3C Option‑1 limits, with acetonitrile ≤ 410 ppm, ethyl acetate ≤ 5000 ppm, and tetrahydrofuran ≤ 720 ppm. A dedicated USP <467> headspace GC‑FID method with a DB‑624 column (30 m × 0.53 mm, 3.0 μm) is employed; oven equilibration at 80 °C for 30 min is mandatory to outgas residual hydrogen chloride that otherwise poisons the flame ionization detector response. For the pivotal amide coupling that installs the pyrrolidine‑tethered 3‑trifluoromethyl‑5,6‑dihydro[1,2,4]triazolo[4,3‑a]pyrazine fragment, the exact stoichiometry is 1.05 molar equivalents of the (3S,4R) acid to 1.00 equivalent of the triazolopiperazine acetate salt. This offset compensates for the trace moisture‑induced hydrolysis of the acyl‑imidazole intermediate. The reaction is monitored by inline Raman spectroscopy; disappearance of the acid carbonyl stretch at 1715 cm⁻¹ correlates with complete conversion in 45–60 minutes at 0–5 °C. The isolated crude DPP-4 inhibitor exhibits a biphasic degradation tendency when stored above 60% relative humidity, forming a ring‑opened diketopiperazine byproduct at 0.05%/day, therefore requiring double‑polyethylene lining and 10 g silica gel desiccant per 25 kg drum. The terminal API is milled to a particle size D₉₀ of <15 μm (Malvern Mastersizer 3000, dry dispersion) to meet the bioavailability specification.
| Solvent | Class | Permitted Daily Exposure (mg/day) | Limit (ppm) | Measured Batch K (ppm) | Measured Batch L (ppm) |
|---|---|---|---|---|---|
| Tetrahydrofuran | 2 | 7.2 | 720 | 310 | 288 |
| Ethyl acetate | 3 | 50.0 | 5000 | 1240 | 980 |
| n‑Heptane | 3 | 50.0 | 5000 | <100 | <100 |
| Acetonitrile | 2 | 4.1 | 410 | <50 | <50 |
| Triethylamine | 3* | 50.0 | 5000 | 2700 | 3200 |
When a Trifluoromethylated Pyrrolidine Acid Becomes a Bifunctional Organocatalyst
The secondary amine embedded in the pyrrolidine ring, combined with the pendant carboxylic acid group, enables a bifunctional acid‑base organocatalysis manifold for the asymmetric conjugate addition of ketones to nitroolefins. Prior to use, the free acid is triturated with 0.25 M lithium carbonate solution to partially deprotonate the carboxylate, generating a lithium salt that exhibits enhanced solubility in water (>100 mg/mL at 23 °C). In a typical loading screen, 5 mol% of the lithium carboxylate catalyzes the reaction between cyclohexanone (1.0 equiv) and trans‑β‑nitrostyrene (1.2 equiv) in deionized water (2.0 mL per mmol of ketone) at 25 °C for 48 hours. Conversion monitored by GC‑MS (HP‑5MS, 30 m × 0.25 mm, 0.25 μm, temperature ramp 15 °C/min from 100 to 280 °C) reaches 95–97%. The syn diastereomer dominates with a dr of >20:1 and an enantiomeric excess of 93%, determined on a Chiralcel OD‑H column (250 × 4.6 mm) using hexane/isopropanol 90:10 at 1.0 mL/min; the major enantiomer elutes at 11.3 min while the minor at 13.8 min. The organocatalyst is reclaimed after work‑up by acidification of the aqueous phase to pH 2.0 with 1 M HCl, precipitating the acid form that is filtered, washed with ice‑cold water, and dried under vacuum (10 mbar, 45 °C) to constant weight. Reuse across four cycles shows a drop in enantioselectivity of <2%, although the yield declines from 88% to 79% owing to gradual accumulation of nitroalkane oligomers. A certificate of analysis supplied for this reagent‑grade application lists assay by non‑aqueous titration (≥98.5%), water content by Karl Fischer (≤0.3%), and specific rotation [α]D20 between −43° and −45° (c 1.0, methanol). The obtained chiral γ‑nitroketone final product feeds into downstream trans‑aminolactam syntheses for γ‑secretase modulator programs. A critical operating boundary governs this process: the presence of more than 5% v/v dimethyl sulfoxide as a co‑solvent erodes enantioselectivity to 78% ee by competing with water for hydrogen‑bonding sites on the catalyst.
| Catalyst loading (mol%) | Water volume (mL/mmol) | Time (h) | Conversion (%) | ee (%) |
|---|---|---|---|---|
| 2 | 2.0 | 72 | 78 | 89 |
| 5 | 2.0 | 48 | 96 | 93 |
| 10 | 2.0 | 30 | 97 | 90 |
| 5 | 1.0 | 48 | 84 | 82 |
| 5 | 4.0 | 48 | 94 | 91 |
Palladium-Catalyzed C–N Cross-Coupling with Phosphine Ligands Derived from the (3S,4R)-Scaffold
Chemical elaboration of the carboxylic acid unit into a tertiary phosphine enables the construction of an air‑sensitive monophosphine ligand that enforces a defined chiral pocket in palladium-mediated Buchwald‑Hartwig aminations. The methyl ester is first prepared (SOCl₂, methanol, 0 °C to reflux, 88% isolated yield) and reduced with lithium aluminum hydride in tetrahydrofuran (1.5 equiv, 0 °C to 20 °C) to give the primary alcohol. Subsequent Mitsunobu coupling with diphenylphosphine oxide (DIAD, Ph₃P, 0 °C to room temperature, 16 h) installs the phosphorus precursor, which is reduced by trichlorosilane in boiling acetonitrile in the presence of triethylamine to deliver the free (3S,4R)-4-(2‑trifluoromethylphenyl)-3‑(diphenylphosphino)pyrrolidine. Because the phosphine is prone to oxidation, all manipulations from this point occur inside a glovebox under an argon atmosphere with continuous oxygen scrubbing (<0.5 ppm O₂). In a typical catalytic run, a catalyst reservoir is produced by stirring Pd₂(dba)₃ (0.5 mol% Pd) with the ligand at a 1.2:1 L:Pd ratio in degassed toluene for 20 minutes. This pre‑catalyst is transferred into a Schlenk flask containing 4‑bromotoluene (1.00 equiv), morpholine (1.20 equiv), and sodium tert‑butoxide (1.40 equiv). The reaction is maintained at 100 °C under argon for 8 hours, after which GC analysis indicates complete consumption of the aryl bromide. The ligand restricts palladium leaching to <4 ppm in the isolated N‑(4‑methylphenyl)morpholine product after filtration through a 0.45 μm PTFE membrane and activated charcoal treatment (5% w/w, 70 °C, 1 h). Residual Pd is quantified by inductively coupled plasma mass spectrometry following USP <232>/<233> protocols; results consistently meet the <5 ppm acceptance limit for late‑phase intermediates. Operating beyond 110 °C triggers ligand decomposition into phosphine oxide, tripling the formation of reductive dehalogenation by‑product to 9% and bleaching the catalytic activity. The conversion of the acid to this ligand is therefore offered as a custom synthesis service, accompanied by ³¹P NMR (δ −20.7 ppm in C₆D₆) and 19F NMR purity certificates.
19F Chemical Shift Anisotropy as a Probe Parameter—Reagent Derivatization at the Pyrrolidine Nitrogen
Because the trifluoromethyl group exhibits a longitudinal relaxation time T₁ of 0.8–1.2 s at 600 MHz (14.1 T) and a chemical shift anisotropy of approximately 45 ppm, the nucleus serves as a highly responsive probe for local dielectric perturbation in protein–ligand binding studies. To construct a ¹⁹F‑containing probe, the pyrrolidine NH is coupled to a pharmacophoric amine via the activated ester route. The acid (1.15 equiv) is dissolved in anhydrous dimethylformamide (0.2 M) and treated with HATU (1.15 equiv) and N,N‑diisopropylethylamine (3.0 equiv) for exactly 5 minutes at 20 °C. The resulting solution is filtered through a 0.2 μm syringe filter directly into a stirred solution of the amine‑biotin derivative (1.00 equiv) in dimethylformamide. Coupling is complete after 30 minutes as judged by LC‑MS (single quadrupole, ESI+) monitoring the disappearance of the amine peak at m/z 492.3. The crude product is precipitated by addition to ice‑cold water (10 volumes), filtered, and purified by preparative reversed‑phase HPLC (C18, 250 × 21.2 mm, 5 μm, gradient 30–70% MeCN in 0.1% TFA over 25 min). The pooled fractions are lyophilized to a white powder with ≥99.0% purity by ¹⁹F NMR (δ −62.3 ppm, DMSO‑d₆, referenced to CFCl₃). A mandatory quality control test involves ¹H‑13C HSQC to ensure no epimerization at the C‑3 position; contamination by the cis‑diastereomer is held to <0.5%. No pharmacopoeial monograph covers this reagent type, but the accompanying certificate of analysis includes HRMS (TOF‑ESI, mass error <3 ppm) and elemental combustion analysis (C, H, N within ±0.4% of theoretical). The terminal biotin‑tagged probe is then used in Carr‑Purcell‑Meiboom‑Gill relaxation dispersion experiments to extract protein‑binding kinetics, and residual HATU‑related by‑products are limited to ≤0.1% by total ion chromatogram to prevent non‑specific protein labeling.
Fmoc-Protected γ-Amino Acid for Atropisomerically Biased Turn Mimetics
To translate the (3S,4R) stereochemical information into solid‑phase peptide synthesis (SPPS), the pyrrolidine nitrogen is protected with a base‑labile 9‑fluorenylmethoxycarbonyl (Fmoc) group. The free acid is combined with Fmoc‑OSu (1.18 equiv) and sodium hydrogen carbonate (2.5 equiv) in a biphasic mixture of dioxane and water (1:1 v/v) at 0 °C. The mixture is allowed to warm to 23 °C over 16 h and then diluted with water and washed with methyl tert‑butyl ether to remove non‑polar impurities. Acidification with 1 M hydrochloric acid to pH 2.8 precipitates the Fmoc‑protected amino acid, which is dried under vacuum (10 mbar, 40 °C) to a constant melting range of 128–131 °C (dec). Analytical HPLC on a Cortecs C18 column (100 × 4.6 mm, 2.7 μm) with a gradient of 50–95% acetonitrile in 0.1% trifluoroacetic acid over 12 min (1.2 mL/min) shows a diastereomeric purity exceeding 99.5%. When this building block is inserted into a growing peptide chain on Rink amide AM resin (loading 0.48 mmol/g), a double‑coupling protocol is employed: first with HBTU (3.92 equiv) and diisopropylethylamine (8.0 equiv) in dimethylformamide for 45 min, followed by a second identical coupling cycle after a dichloromethane wash. Fmoc‑deprotection yields a UV absorption signal at 304 nm that corresponds to 99.3% coupling efficiency. The 4‑trifluoromethylphenyl ring creates a conformational restriction that mimics a γ‑turn: the pyrrolidine ring adopts an envelope conformation with the aryl group in a pseudo‑equatorial position, and the barrier for pseudorotation is measured by variable‑temperature NMR in DMF‑d₇ at 14.5 kcal/mol. The resulting macrocyclic pentapeptide targets integrin αvβ3 and displays a half‑life exceeding 120 min in human plasma stability assays (37 °C, phosphate‑buffered saline pH 7.4). Compliance documentation for the Fmoc‑derivatized reagent includes absence of free secondary amine (negative to FDNB spot test), water content ≤ 0.25%, and a confirmed [M+H]⁺ mass by LC‑MS that matches theoretical within ±0.5 Da. Production‑scale separation of Fmoc‑diastereomers, if required, is performed on a 200 mm internal diameter dynamic axial compression column with Chiralpak IC (10 μm) and a mobile‑phase consumption of 0.8 L/h.
Free-Acid Storage Under Nitrogen and Its Role in Minimizing Acyl-Imidazole Epimerization During Plant Trials
A recurring deviation encountered during pilot‑plant validation runs involves the gradual formation of 0.4–0.7 area% of the (3R,4S) epimer in the free acid inventory after 90 days of storage in standard low‑density polyethylene bags at 25±2 °C and 60% RH. This degrades the downstream SN2‑type coupling outcome because the undesired enantiomer exhibits an electronically identical mass spectrum and co‑elutes on achiral reversed‑phase methods. To suppress the epimerization, the acid is repackaged under oxygen‑free dry nitrogen (dew point ≤ −45 °C) into triple‑laminated aluminum barrier bags with an inner PET‑Al‑PE composite and 10 g molecular sieve desiccant (3Å) per 25 kg. Under these conditions, enantiomeric integrity at 99.6% is maintained for 24 months at controlled room temperature per ICH Q1A(R2) stability data. The acid is later converted to its 2,5‑dioxopyrrolidin‑1‑yl (OSu) active ester for cleanly generating amide bonds. In a 300 L Hastelloy reactor, the acid is treated with N‑hydroxysuccinimide (1.03 equiv) and N,N’‑diisopropylcarbodiimide (1.05 equiv) in acetonitrile at –10 °C. The batch is stirred at 150 rpm (retreat‑curve impeller) for 4 h while the jacket is held at –8 °C. Excessive hold time beyond 6 h leads to a 0.2%/h growth of the enantiomeric impurity due to reversible oxazolone formation; therefore inline FTIR monitoring of the N‑hydroxysuccinimide ester carbonyl band at 1815 cm⁻¹ triggers immediate filtration over Celite (1.0 kg) and cold solvent removal (20 °C bath, ≤100 mbar). The dried OSu ester is titered by HPLC (external calibration, purity >98.5 area%) and directly fed to the final amine coupling within 48 h. Active ester moisture sensitivity demands that all reactor charging hoppers are flushed with dry nitrogen for 10 min prior to transfer, and the ambient humidity in the production suite is maintained below 35% RH per ISO 14644‑1 Class 8 cleanroom monitoring.
